Press release
Global Metabolic Disorder Therapeutics Market Size, Industry Trends, Share and Forecast 2020-2026
The global metabolic disorder therapeutics market is estimated to grow at a CAGR of 7.8% during the forecast period. An increasing number of clinical trials have been witnessed over the years owing to the rising prevalence of metabolic disorders and increasing demand for more effective treatment. For instance, in May 2020, POXEL SA, a biopharmaceutical company focused to develop innovative treatments for metabolic disorders, such as non-alcoholic steatohepatitis (NASH) and type 2 diabetes declared new preclinical results for PXL770. It is a direct adenosine monophosphate-activated protein kinase(AMPK) activator, was assessed in a rodent NASH model along with other major agents in development, such as a thyroid receptor ? agonist (MGL-3196), an FXR agonist (obeticholic acid), and a GLP-1 receptor agonist (semaglutide).To Request a Sample of our Report on Global Metabolic Disorder Therapeutics Market: https://www.omrglobal.com/request-sample/metabolic-disorder-therapeutics-market
The outcomes feature PXL770 as a potential new NASH therapy that may develop complementary advantages while combined with other agents with different action mechanisms. Further, in September 2020, Kaleido Biosciences, Inc. declared that it has evaluated Microbiome Metabolic Therapy (MMT) candidate KB295 in the first patient suffering from mild-to-moderate ulcerative colitis. Such kinds of clinical studies are offering an opportunity for new launches of innovative therapies for metabolic disorders, which in turn, will further accelerate the market growth.
Scope of the Global Metabolic Disorder Therapeutics Market
Market Coverage
· Market number available for 2019-2026
· Base year- 2019
· Forecast period- 2020-2026
· Segment Covered- By Therapy and Disease
· Regions Covered- North America, Europe, Asia-Pacific, and Rest of the World
· Competitive Landscape- AbbVie, Inc., Novo Nordisk A/S, Sanofi SA, Boehringer Ingelheim GmbH, and AstraZeneca plc
Recent Strategic Initiatives in the Global Metabolic Disorder Therapeutics Market
· In March 2020, AstraZeneca plc declared the collaboration with Silence Therapeutics for discovery, development, and commercialization of small interfering RNA (siRNA) therapeutics to treat CVD, respiratory, renal, and metabolic disorders. This multi-target partnership will use the established small interfering RNA (siRNA) platform of Silence to detect and progress liver-based targets and develop new delivery methods to target other tissues including the heart, kidney, and lung.
· In March 2020, Eli Lilly and Co. declared the global licensing and research partnership with Sitryx, a biopharmaceutical company engaged in the development of therapeutics in immuno-inflammation and immuno-oncology. Under the partnership, the companies will study up to four new preclinical targets that are identified by Sitryx that could result in potential new medicines for autoimmune diseases. Lilly will make a $10 million equity investment in Sitryx and Sitryx will get an upfront payment of $50 million.
Key questions addressed by the report
· What is the market growth rate?
· Which segment/region dominates the market in the base year?
· Which segment/region will project the fastest growth in the market?
· How COVID-19 impacted the market?
o Recovery Timeline
o Deviation from the pre-COVID forecast
o Most affected region/segment
· Who is the leader in the market?
· How players are addressing challenges to sustain growth?
· Where is the investment opportunity?
·
(Get 15% Discount on Buying this Report)
A full Report of Global Metabolic Disorder Therapeutics Market is Available at: https://www.omrglobal.com/industry-reports/metabolic-disorder-therapeutics-market
Global Metabolic Disorder Therapeutics Market-Segmentation
By Therapy
· Drug Therapy
· Gene Therapy
· Cellular Transplantation
· Enzyme Replacement Therapy
· Others
By Disease
· Obesity
· Diabetes
· Lysosomal Storage Disease
· Hypercholesterolemia
· Others
Global Metabolic Disorder Therapeutics Market– Segment by Region
North America
· United States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest of Europe
Asia-Pacific
· India
· China
· Japan
· South Korea
· Rest of APAC
Rest of The World
· Latin America
· Middle East & Africa
Company Profiles
· AbbVie, Inc.
· Actelion Pharmaceuticals, Ltd.
· Agios Pharmaceuticals, Inc.
· Alexion Pharmaceuticals, Inc.
· Amgen, Inc.
· AstraZeneca plc
· Biocon, Ltd.
· BioMarin Pharmaceutical, Inc.
· Boehringer Ingelheim GmbH
· Bristol-Myers Squibb Co.
· Cipla, Inc.
· CymaBay Therapeutics, Inc.
· Dracen Pharmaceuticals, Inc.
· Eli Lilly and Co.
· Intra-Cellular Therapies, Inc.
· Merck KGaA
· Novo Nordisk A/S
· Orchard Therapeutics plc
· Pfizer, Inc.
· Sanofi S.A.
· Shire Pharmaceuticals Group plc
· Sigilon Therapeutics, Inc.
· Silence Therapeutics
Reasons for Buying from us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/metabolic-disorder-therapeutics-market
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Metabolic Disorder Therapeutics Market Size, Industry Trends, Share and Forecast 2020-2026 here
News-ID: 2400611 • Views: …
More Releases from Orion Market Research

Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sust …
Hair accessories market was valued at $23.8 billion in 2024 and is projected to reach $55.2 billion in 2035, growing at a CAGR of 8.2% during the forecast period (2025-2035). Generation Z, with significant disposable income, is transforming the hair accessories category in a major way. Their close connection to trends creates a unique feeling of urgency to self-express through fashion, such as clips, scrunchies, and barrettes. It has become…

Railway Management System Market Size Analysis, Competitive Insights, Leading Pl …
Railway System (or Railway Management System) market was valued at approximately USD 28.28 billion, and it is expected to reach about USD 45.19 billion by 2033, growing at a CAGR of around 4.8% from 2024 to 2033.
Railway Management System Market Overview
The Railway Management System market includes technologies and systems used to plan, monitor, and manage railway operations-everything from traffic and signaling systems to asset and maintenance management, passenger information,…

Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Player …
Monocalcium Phosphate market was valued at about USD 4.2 billion, and it is anticipated to reach around USD 6.9 billion by 2033, growing at a CAGR of approximately 5% from 2023 to 2033.
Monocalcium Phosphate Market Overview
Monocalcium phosphate (MCP) is a calcium-phosphorus compound widely used in animal feed, fertilizers, and also in food and beverage applications (for example as leavening agent or acidity regulator), due to its solubility and bioavailability. The…

Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Player …
Automotive Lubricants Market was valued at approximately USD 70.44 billion. By 2033, it is expected to reach around USD 107.09 billion, growing at a CAGR of about 3.3% from 2025 to 2033.
Automotive Lubricants Market Overview
The automotive lubricants market consists of products like engine oils, gear oils, greases, hydraulic fluids, and transmission fluids that reduce friction, wear and tear, and improve efficiency and lifespan of vehicle components. Demand is driven by…
More Releases for Therapeutics
Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | …
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years.
DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Some of the…
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme …
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years.
DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,…
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN …
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611
Focused on growth…
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, …
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan.
Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Hodgkin's…
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep …
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space.
Key Takeaways from…
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant…